To Evaluate the Efficacy and Safety of JPI-547 in Combination With Bevacizumab as Maintenance Therapy in Relapsed Ovarian Cancer
Clinical trial NCT07370818 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07370818
- Sponsor
- Onconic Therapeutics Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-27
- Primary completion
- 2029-12-31
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.